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Abstract 
Rationale: Desorption electrospray ionization-mass spectrometry (DESI-MS) has 
demonstrated utility in differentiating tumor from adjacent normal tissue in both urologic and 
neurosurgical specimens. We sought to evaluate if this technique had similar accuracy in 
differentiating oral tongue squamous cell carcinoma (SCC) from adjacent normal epithelium 
due to current issues with late diagnosis of SCC in advanced stages. 
Methods:  Fresh frozen samples of SCC and adjacent normal tissue were obtained by 
surgical resection.  Resections were analyzed using DESI-MS sometimes by a blinded 
technologist. Normative spectra were obtained for separate regions containing SCC or 
adjacent normal epithelium.  Principal Component Analysis and Linear Discriminant 
Analysis (PCA-LDA) of spectra were used to predict SCC versus normal tongue epithelium. 
Predictions were compared with pathology to assess accuracy in differentiating oral SCC 
from adjacent normal tissue. 
Results: Initial PCA score and loading plots showed clear separation of SCC and normal 
epithelial tissue using DESI-MS.  PCA-LDA resulted in accuracy rates of 95% for SCC 
versus normal and 93% for SCC, adjacent normal and normal.  Additional samples were 
blindly analyzed with PCA-LDA pixel by pixel predicted classifications as SCC or normal 
tongue epithelial tissue and compared against histopathology. The m/z 700-900 prediction 
model showed a 91% accuracy rate.   
Conclusion:  DESI-MS accurately differentiated oral SCC from adjacent normal epithelium.  
Classification of all typical tissue types and pixel predictions with additional classifications 
should increase confidence in the validation model.   
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Introduction 
Oral Cavity Cancer  
Cancers of the oral cavity and oropharynx are the most common head and neck tumors 
in the United States.1  Worldwide, around 600,000 people are afflicted by head and neck cancer 
every year.2   Oral cancer has an age normalized incidence rate of 3.9 per 100,000 persons 
worldwide.3  Common risk factors for developing oral cancer are alcohol consumption and 
tobacco use with a rising incidence of oropharyngeal cancer (more specifically, tonsil and base 
of tongue cancer) related to human papilloma virus (HPV) infection.3 
Oral cancer patients typically are diagnosed at an advanced stage of invasive squamous 
cell carcinoma (SCC) at the time of diagnosis.4  Owing to delayed disease presentation in 
patients and lack of appropriate screening techniques to identify early oral cancer, roughly half 
of patients survive five years from initial disease diagnosis.2  The five year oral cancer mortality 
rate has not changed greatly in over 50 years4 despite surgical advances, and improvements in 
radiotherapy and chemotherapy.  Oral cancer not only has a very high recurrence rate, but those 
who survive a first occurrence also have up to a 20 fold increased risk of developing a second 
primary cancer3 (i.e., another oral SCC) which is the highest second-malignancy rate for all 
cancers.4   The most common cause of treatment failure and death in oral cancer patients is 
local recurrence of their primary tumor.5 
The high frequency of patients presenting with advanced disease is puzzling.  Oral 
cancer is located in the oral cavity where the oral surface epithelium is readily accessible to 
visual and tactile examination.  Health care providers, specifically dentists, typically examine 
their patient’s oral cavity on a semi-annual basis providing a consistent and reliable opportunity 
for a visible and palpable examination of areas at risk. 
Current Oral Cavity Screening methods  
Current methods in oral cavity cancer screening (e.g. visible and palpable examination 
of oral cavity by a dentist, brush tests, toluidine blue staining, and light-based detection 
systems) do not seem to definitively determine the presence of cancer or precancerous lesions.6  
Conventional oral examination (COE) is currently a controversial mainstay of oral cancer 
screening.4,7  Brush tests act more as a case-finding modality by interrogating clinical lesions 
that would not typically undergo tissue biopsy and pathological evaluation.  However, since 
not all subjects interrogated by brush test undergo tissue biopsy and pathological evaluation, 
their accuracy is still unclear.4   
One study evaluated the use of toluidine blue to detect lesions that had not been detected 
by COE8  concluding that the staining test was sensitive (92%) but not specific (42%) since 
there is no consensus on what shade of blue is a positive result.4 
The lack of comparison of light-based detection system test results to pathological 
evaluation makes sensitivity, specificity and similar calculations impossible.4  A case-finding 
study of 44 patients with a history of oral dysplasia or head and neck SCC (HNSCC) evaluated 
by tissue fluorescence resulted in a 98% sensitivity and 100% specificity in discriminating 
cancer or dysplasia from normal oral mucosa.9 
Currently the only definitive method of detection is by biopsy and pathological 
evaluation of removed tissue.10,11  However, even in this circumstance, while evaluation by the 
pathologist is directed by numerous criterion for diagnosis, it still is inherently subjective.  
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Desorption Electrospray Mass Spectrometry as a diagnostic method  
Subjective histopathological analysis would likely be improved by objectively relating 
pathological states to chemical information obtained by desorption electrospray ionization – 
mass spectrometry (DESI-MS).12,3,13,1 
As established in several other organ systems, DESI-MS imaging of lipid profiles in 
tissue can be correlated with histopathological characterization.14  DESI-MS benefits from 
minimal sample handling beyond what is needed for frozen section pathological evaluation 
making DESI-MS well suited for case finding.  Previous work in brain surgery15 has 
differentiated types of gliomas and meningiomas, including tumors of different histological 
grades and tumor cell concentrations, and was validated during intraoperative use16. 
There is an urgent need for earlier objective detection of oral cancer for diagnosis and 
prognosis.  A goal of this  project is to develop a new diagnostic aid that could help a health 
care professional, such as a general dentist or dental specialist, more readily identify and assess 
oral tissue of uncertain biological significance, defined as case-finding.4 
Methods and Materials 
Tissue Specimens 
IUSOM and UC Davis (UCD) research tissue specimens were collected during tumor 
removal surgeries conducted by Dr. Michael G. Moore, MD, FACS (otolaryngologist, 
previously at IUSOM and currently at UC Davis Medical Center) and other surgeons in the 
Department of Otolaryngology-Head and Neck Surgery at Indiana University and at UC Davis 
Medical Center.  Each institution collected fresh frozen normal and SCC tissue specimens from 
the oral cavity of consented patients undergoing treatment following an IU IRB approved 
procurement protocol.  This study was carried out in strict accordance with the UCD, IU and 
Purdue IRB protocols.   
Most specimens were matched, meaning that both normal and SCC specimens were 
procured from the same patient.  Thirty-two normal and SCC specimens were acquired from 
an IUSOM tissue bank. Sixty-two normal and SCC specimens were acquired from UC Davis. 
All specimens were shipped on dry ice to Indiana University Health Pathology Lab 
(IUHPL) where the specimens were cryosectioned to 15 µm thickness and thaw mounted to 
glass microscope slides. Tissue-Tek O.C.T. (Sakura Finetek) was used as the embedding agent. 
Regarding thaw mounting, typically two tissue sections were thaw mounted per slide and 
multiple slides were prepared per specimen.  Sections were stored at -80°C prior to ambient 
ionization MS analysis.  -80° C sections were vacuum dried for 15 minutes prior to DESI-MS 
imaging analysis.   
DESI-MS imaging 
A laboratory-built DESI ion source was coupled to a linear ion trap mass spectrometer 
(LTQ) controlled by Xcalibur 2.0 software (ThermoFisher Scientific, Waltham, MA).  The 
LTQ MS and Xcalibur software were used in all experiments.  The embedding agent used for 
tissue cryosectioning produces significant background signals in the positive ion mode but not 
in the negative ionization mode. For this reason, we chose to use negative ionization for all 
experiments.  For DESI experiments, the automatic gain control (AGC) was inactivated.  Each 
tissue section selected for analysis was DESI-MS imaging analyzed using morphologically 
friendly spray solvent,17 dimethylformamide-acetonitrile (1:1) solution.  Both solvents were 
purchased from Mallinckrodt Baker Inc. (Phillipsburg, NJ) and delivered at a flow rate of 2.0 
µL min-1 using the instrument syringe pump.  The DESI source parameters were set as follows: 
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capillary temperature 275 °C, voltage applied to the stainless steel needle syringe 5 kV, 
capillary voltage -25 V, tube lens voltage -115 V, capillary incident angle 52°, spray to surface 
distance ~3 mm, sample to inlet distance ~5 mm, and nitrogen gas at 180 psi.  The LTQ was 
set to an injection time of 250 µs and two microscans.  Tissue sections were analyzed using a 
moving stage with a lateral (“x” axis) scan rate of 307.69 µm s-1 in horizontal rows separated 
by a 200 µm vertical step (“y” axis).18  Instrument scan time was coordinated with scan speed 
providing ~200 x 200 µm pixels.  Full scan mass spectra were acquired in negative ion mode 
in the mass range m/z 200-1000 for each tissue section.   
Pathology 
The same slide analyzed by DESI-MS imaging was hematoxylin & eosin (H&E) stained, 
photographed, cover slip mounted, and histopathologically evaluated by an expert 
pathologist, (DJS).  The sections were evaluated to identify regions of normal epithelium and 
SCC.  Other tissue types such as abnormal, premalignant, or precancerous epithelium, 
skeletal and smooth muscle, fat, connective tissue, blood vessels, and the like were observed 
and noted during histological evaluation.  As illustrated by a tissue section in Figure 1A and 
B, normal epithelial and squamous cell carcinoma regions of interest were delineated by line 
annotations.     
Twelve normal and SCC IUSOM specimens were excluded from further analysis 
because the evaluated sections did not include either regions of normal epithelium or SCC.  
Sixteen of the sixty-two specimens acquired from UCD were excluded from further analysis 
because the evaluated sections did not include either regions of normal epithelium or SCC.  All 
histological evaluations were provided only after DESI-MS imaging and pixel prediction 
model analysis. The researchers conducting DESI-MS imaging and pixel prediction model 
analysis were blinded to initial diagnosis information. 
BioMap for DESI-MS Imaging selection of Pixels of Interest 
BioMap (Novartis Institutes for BioMedical Research, Basel Switzerland)18 was used 
to correlate histologically evaluated annotations to identify DESI-MS image pixels of 
interest.  An in-house data conversion software, ImgConverter v3.0, was used to compile and 
convert Xcalibur MS data files (*.raw) into BioMap compatible ANALYZE format files 
(*.img).19  BioMap allows visualization of the mass spectrum associated with each 
individual, “x”, “y” position as well as mass spectra processing (e.g., mean and background 
subtraction) and selection of a region of interest by selection of x,y positions.  Each x is a 
mass spectrum acquired along y horizontal row.  Each x,y position is defined as a pixel.   
All BioMap pixels assignments are based on histological evaluations provided by Dr. 
Summerlin independent of DESI analysis and imaging. Pixels of interest were highlighted 
conservatively, typically excluding tissue adjacent to line annotations, even to the exclusion 
of normal epithelial tissue from the pixels of interest. 
One matched case of samples was excluded from DESI-MS imaging because normal 
epithelial could not be distinguished from connective for IUSOM Sample 30 and SCC tissue 
could not be distinguished from surface epithelial tissue for Sample 31. Specifically, BioMap 
m/z values could not visualize the tissue section in order to correlate BioMap pixels with 
histopathological evaluation.   
Histology based regions of interest are translated into histologically guided selection 
of pixels of interest.  Average mass spectra were obtained by averaging regions of interest.  
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Figures 1C and 1D display average mass spectra for squamous cell carcinoma and normal 
epithelial regions of interest, respectively, in Sample 35.   
DESI-MS Image Data Processing 
A data conversion software, ProteoWizard specifically MSConvertGUI, was used to 
convert Xcalibur MS data files (*.raw) into mzXML files (*.mzxml).19 
Multivariate Statistical Analysis 
Twenty-one DESI-MS averaged mass spectra from twenty separate IUSOM samples 
were used to create normal and SCC mass spectral test set databases.  For DESI averaged mass 
spectra, regions annotated by pathology as normal epithelium or SCC with no other 
characterization were selected as groups of pixels of interest composed of the mass spectra at 
each pixel.  Again, average mass spectra were obtained by averaging regions of interest.   
Principal Component Analysis (PCA) 
BioMap exported an average mass spectrum from the pixels of interest.  Each average 
mass spectrum’s list of m/z values and ion abundances was imported into Excel (Microsoft, 
Spokane, WA USA). Excel spreadsheets were used to import into Matlab (The MathWorks, 
Inc., Natick, MA USA).  In-house scripts were used to transform each average mass spectrum 
by standard normal variate (SNV).  All spectra for each DESI dataset were mean-centered for 
the same m/z value across all samples.  PCA was performed on total ion count (TIC) 
normalized or SNV transformed, mean-centered data for DESI datasets.   
Principal Component Analysis - Linear Discriminant Analysis (PCA-LDA) 
Models were built using all of the objects based on each analyzed target set.  Linear 
Discriminant Analysis (LDA) was applied on the DESI target datasets of SNV transformed, 
column centered mass spectra after compression by PCA, thereby using as variables the 
principal components instead of the original mass spectral data.  LDA was performed as a 
supervised discriminant classification technique.  Discriminant methods look for a delimiter 
that divides the global domain into a number of regions, each assigned to one of the classes.  
This delimiter identifies an open region for each class and such regions determine the 
assignment of the samples to one of the classes.10  Model validation, specifically evaluation 
of the predictive ability of the model, was performed by means of cross-validation (CV).10  
For this study, five cross-validation deletion groups were selected, meaning that all of the 
samples (DESI dataset n=21) were divided five times systematically in a training set and a 
test set, with all of the samples being in the test set only once.  A training set means objects 
were used for building the classification model.  A test set means non-training set objects 
were used to evaluate the predictive ability of the model. 
Pixel predictions and cross validations were used to estimate the sensitivity, 
specificity, and global prediction rate for all classes, as the CV prediction rate for each class, 
known as the complete validation strategy.10  For CV prediction rate, sensitivity measures the 
proportion of subjects with the disease who test positive, while the specificity determines the 
proportion without the disease who test negative.  For pixel prediction, sensitivity measures 
the proportion of tissue sections with squamous cell carcinoma, where the majority of the 
pixel predictions in the same region of tissue section were predicted squamous cell 
carcinoma, while the specificity determines the proportion of tissue sections with normal 
epithelial tissue where the majority of the pixel predictions in the same region of tissue 
section were predicted as normal epithelial tissue.   
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The predictive values determine the proportion of subjects with positive and negative 
test results that either do or do not have the disease.  For pixel prediction, the prediction rate 
is the percentage of correct predictions on the objects in the test set relative to pathology.  
The CV prediction rate is the percentage of correct predictions on the objects in the CV test 
set.  The confusion matrix shows how many samples belong to a certain category were 
correctly/incorrectly assigned by the classification rule to that category.  In each matrix, each 
element gives the number of samples of the row category assigned to the column category.  
When a matrix includes only entries on the diagonal (e.g., there are no entries outside the 
main diagonal) there is perfect prediction of all the samples.   
LDA models used for supervised discriminant classification were built using a range 
of two to six PCs.  The models were chosen which provided the least number of false results 
(e.g., highest prediction rates) in cross validation.  
Univariate Statistical Analysis 
One way analysis of variance (ANOVA) was performed on the TIC normalized 
intensities for a subset of the detected ions using Origin Pro 2017 (OriginLab, Northampton, 
MA). The reported p-values result from the F-test comparing the mean TIC normalized ion 
intensities between the normal oral epithelial tissue samples and the oral SCC samples. P-
values much less than 0.05 indicate that there is a significant difference between the two 
experimental groups for the specified m/z value. Statistical power analysis, a description of 
the probability of detecting a difference in means between experimental groups, was 
performed using JMP (SAS Institute, Cary, NC). Power ranges from 0 to 1; a power of 1 
means that the probability of detecting an effect is 100% given that there is an effect to be 
detected. 
Results 
Three mass ranges of 200-400, 400-600, and 700-900 were used for data analysis of 
each DESI image.  Two mass ranges (m/z 200-1,000 and 700-900) were used for pixel by pixel 
prediction models.    Mass range 200-400 limits biochemical information to fatty acids, mass 
range 400-600 to fatty acid dimers, and 700-900 to complex phospholipids. All samples were 
analyzed using DESI-MS imaging over three consecutive days. 
DESI-MS Imaging on Oral Tongue Cancer Samples 
Regions of interest were correlated with histologically evaluated annotations by using 
specific m/z values. For example, Sample 35 histological evaluation identified a region of 
normal epithelial tissue as illustrated in the top left portion of Figure 1A, above.  BioMap 
images of  Sample 35 at m/z 465 (cholesterol sulfate)20, 563 (dimer of oleic acid)21 and 885 (PI 
38:4)21,22 each illustrated regions of increased ion intensities corresponding to specific 
histologically evaluated regions of interest (see Figure 1A parts 1-4). Exact mass measurements 
and fragmentation studies were performed on these ions, as well as others, to support their 
tentative identifications (Figures S1, S2, Table S1, supplementary information). Sample 36 
histological evaluation also identified a region of normal epithelial tissue as illustrated in the 
top right portion of Figure 1B. 
To evaluate the accuracy of DESI-MS in differentiating oral tongue SCC from adjacent normal 
epithelium, PC1 vs. PC2 Score plots were then created to observe the separation of normal 
epithelial and SCC average mass spectra within the samples (Figure 2). 
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Loading plots (Figure 2B and Supplemental Figures 3B, 3D, and 3F) indicate which 
m/z values contribute to separation of samples in score plots (Figure 2A and Supplemental 
Figures 3A, 3C, and 3E).  The loading plots seem to suggest that m/z 281, 563, and 885 each 
aid to separate SCC from normal while m/z 465 and 788 each contributes to distinguish normal 
from SCC.  Supplemental Figure 1F suggests that m/z 794 (PC 36:1 + Cl-)23 / (PE 40:4)21 and 
885 (PI 38:4)21,22 each contribute to the variation in normal epithelial and SCC average mass 
spectra. 
Space charged m/z 281, 465, and 788 peaks are evident in broadened loading values. In 
response, we chose to evaluate the maximum value for each m/z.  As illustrated in Figure 3, 
One Way ANOVA of TIC normalized normal epithelial and squamous cell carcinoma values 
at maximum value m/z 281 has a p value of 1.15*10-3, maximum m/z 563 has a p value of 
4.6*10-3 and maximum value m/z 465 has a p value of 8.55*10-5. Power analysis provided 
values of 0.95, 0.99, and 0.98 for m/z 281, 563, and 465, respectively. The fold-change in the 
mean values, normal epithelial tissue relative to SCC, were 0.53, 0.27, and 9.37 for m/z 281, 
563, and 465, respectively. These univariate results show that m/z 281, 563, and 465 may be 
strong discriminators between normal epithelial tissue and oral SCC and they warrant future 
study. 
PCA-LDA was performed on the DESI-MS imaging averaged mass spectra to 
distinguish between normal epithelial and SCC.  LDA is useful to build a classification model 
capable of predicting the disease state of unknown samples.10 The DESI data comprised normal 
epithelial tissue including eight measurements (n=8) and squamous cell carcinoma including 
thirteen measurements (n=13).  The range of two and four PCs were used for classification.  
Several combinations of PCs and deletion groups did not significantly increase the highest 
prediction rates for both classes (normal epithelial and SCC).  The range of PCs confirms that 
the results obtained are relatively stable.  The average cross-validation (CV) prediction rate was 
95%.  The number of false results per class obtained through cross-validation can be seen in 
Table 1.  In Table 1 histopathology is the control testing method and PCA-LDA of DESI-MS 
imaging is the testing method under evaluation.  Multivariate Statistical Analysis, specifically 
Principal Component Analysis-Linear Discriminant Analysis (PCA-LDA), is used as the 
method or test applied to DESI-MS imaging data. 
PCA-LDA was performed on each selected pixel in each of the sixty-two UC Davis 
samples.  Histopathology regions of normal epithelial tissue and squamous cell carcinoma were 
correlated with m/z 200-1,000 and m/z 700-900 pixel predictions. For example, histological 
evaluation of Sample 43 identified a region of normal epithelial tissue and a region of squamous 
cell carcinoma as illustrated in Fig. 4C.   
 
As illustrated in Figure 5, both pixel prediction models (m/z 200-1,000 and m/z 700-
900) correctly predict normal epithelial for UC Davis Sample 30 with only a few pixels in the 
m/z 200-1,000 pixel model predicted as squamous cell carcinoma.  Both pixel prediction 
models predicted skeletal muscle as squamous cell carcinoma because the prediction models 
have only one of two classes to choose from either normal epithelial or squamous cell 
carcinoma.  We expect that creation of additional classes for dysplastic epithelium, skeletal and 
smooth muscle, fat, connective tissue, and blood vessels will increase prediction rates for 
heterogeneous tissue samples. 
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Forty-four of the acquired sixty-two UC Davis samples included either normal 
epithelial and/or squamous cell carcinoma.  Two samples (UC Davis Samples 24 and 43) 
included both normal epithelial tissue and squamous cell carcinoma providing a total 
population of 46.  All histopathology regions of normal epithelial and squamous cell carcinoma 
were compared to both pixel validation models. The m/z 700-900 pixel prediction model had 
91% accuracy while the m/z 200-1000 pixel prediction model was 76% accurate (data not 
shown).  In Table 2 histopathology is the control testing method and m/z 700-900 pixel 
validation method by PCA-LDA is the testing method under evaluation.   
Discussion 
In the current work, DESI-MS imaging of frozen tissue sections detected differentiating 
MS lipid profiles of SCC and normal samples.  We note that this is a first exploration of the 
differential chemical signals between normal and SCC using DESI-MS imaging to oral cancer.  
PCA-LDA provided 95% accuracy.  One Way ANOVA of TIC normalized normal epithelial 
and squamous cell carcinoma values at maximum value m/z 281, maximum m/z 563 and 
maximum value m/z 465 each had p values less than 0.01.   The current work benefits by 
interrogating all tissue biopsies by DESI-MS imaging and histopathological evaluation.  The 
inclusion of comparison of DESI-MS imaging results against pathological evaluation provides 
confidence in sensitivity and specificity values.  The objective data can be collected into 
databases, sorted by clinical outcome data, and further analyzed to provide more accurate 
profiles of histopathological tissue types and disease states.  The collected data can then be 
used to minimize patient variability and provide better classification algorithms and improved 
confidence intervals. 
DESI-MS can measure differences in lipid profiles based on lipid based biochemical 
changes such as fatty acid synthase (FAS). Lipid based biochemical changes, such as 
overexpression of FAS, have been reported for oral SCC.24  The DESI-MS imaging data 
supports this previous finding. FAS plays a central role in the endogenous synthesis of long 
chain fatty acids from acetyl-CoA and malonyl-CoA.24  Several human cancers, including oral 
SCC, constitutively express high levels of FAS and consequently have an active endogenous 
fatty acid biosynthesis.  FAS is higher in oral SCC than in the adjacent morphologically normal 
epithelium.24    
In our experiments, the greater relative intensity of cholesterol sulfate (CS) by DESI-
MS imaging in normal regions of interest compared to SCC regions of interest (see Figures 1A 
and 1B part 3) supports previous literature findings.  A prior independent study25 examined 
abundance of cholesterol sulfate in normal epidermal and squamous cell carcinoma cells in the 
process of squamous differentiation from growth phase to confluence.  At confluence, normal 
epidermal cells undergo terminal differentiation and expression of the differentiated phenotype 
except for a variant with defects in terminal differentiation control.  Normal epidermal cells 
except for the variant experienced a greater than 30 times accumulation of cholesterol sulfate.  
The variant and squamous cell carcinoma each exhibited less than 3 times accumulation of 
cholesterol sulfate. Their hypothesis is that increased cholesterol sulfate is a marker for 
squamous differentiation. 
Oral cancer, like most carcinomas, arises through progressive histopathologic changes. 
As a result, these ambient ionization methods should detect differences in lipid-based 
morphological changes.  Current visible and light based detection systems are not as objective 
and provided less molecular information than MS-based methods.  As previously mentioned, 
DESI-MS imaging lipid profiles in tissue can be correlated with histopathological 
characterization.14  DESI-MS analysis of oral cancer has now been shown to do the same.  We 
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also expect DESI-MS to provide diagnostic information before normal epithelium transitions 
completely from normal to SCC.  In other words, we anticipate that mucosa with significant 
precancerous changes (severe dysplasia or carcinoma in situ) would have DESI-MS profiles 
different from adjacent normal epithelium.   
We acknowledge that the data analyzed so far has been based on analysis of known 
histopathology results and averaging of selected regions of interest.  Furthermore, tissue 
heterogeneity so far limits the approach to not mixed regions of histopathology, and our study 
has a relatively limited number of data points.  We hypothesize that, similar to other DESI-MS 
based oncology studies, larger data sets and more detailed pathological evaluation will improve 
classification of SCC and normal samples as well as differentiate adjacent normal epithelial 
samples. The ultimate test being the application of this methodology on samples of unknown 
histopathology and comparison of DESI-MS prediction with that of traditional histopathology.  
For the pixel prediction models, histopathology regions of normal epithelial and 
squamous cell carcinoma were compared to m/z 200-1,000 and m/z 700-900 pixel validation 
models.  As illustrated in Figures 4 – 5, both pixel prediction models (m/z 200-1,000 and m/z 
700-900) typically provided a correct prediction of squamous cell carcinoma and normal 
epithelial tissue.  The prediction models, however, are limited to two classifications (SCC or 
normal epithelium) and this limits the successful application of the technique.  Creation of 
additional classes (such as skeletal muscle, fat, fibrous tissue, etc.) should increase prediction 
rates for heterogeneous tissue samples. 
Overall m/z 700-900 pixel validation model by PCA-LDA provided 91% accuracy.  
More work is needed to confirm this method and classification of all typical tissue types and 
pixel predictions with additional classifications should increase confidence in the validation 
model.  Analysis of different m/z ranges, such as m/z 200-400 (which includes oleic acid at m/z 
281) and 400-600 (which includes cholesterol sulfate at m/z 465 and oleic acid dimer at m/z 
563) may provide high accuracy rates.  Additional m/z ranges may confirm existing validation 
models. 
On top of these challenges, some additional issues persist.  As illustrated in Figure 6, 
both pixel prediction models (m/z 200-1,000 and m/z 700-900) fail to correctly predict regions 
of normal epithelial tissue adjacent to squamous cell carcinoma (UC Davis Sample 24).  
Similarly, as illustrated in supplemental Figure 5, both pixel prediction models (m/z 200-1,000 
and m/z 700-900) incorrectly predict normal epithelial in one sample (UC Davis Sample 9).  
Analysis of the average mass spectra can be used to explain the normal epithelial tissue 
prediction but not why the prediction was incorrect.  The intermittent inability to correctly 
predict normal epithelial tissue adjacent to squamous cell carcinoma in oral samples has been 
a consistent limitation of this methodology.  This is likely due to the fact that adjacent tissue, 
while normal in appearance histologically, actually demonstrates premalignant changes on a 
molecular level, thus signaling that it may be at risk for future carcinogenesis.  Moreover, 
squamous cell carcinoma can have differing degrees of differentiation that may lead to different 
cellular lipid profiles, possibly making it more or less easily discerned from adjacent normal 
epithelium.  Creation of an additional class for normal epithelial tissue adjacent to squamous 
cell carcinoma, as well as different norms for the spectrum of premalignant change (severe 
dysplasia and carcinoma in situ) and tumor differentiation, should increase prediction accuracy 
through a larger dataset of these different categories.  This may be an area of future study. 
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Conclusion 
This work suggests that DESI-MS may be useful in the diagnosis of oral tongue 
squamous cell carcinoma. The time for DESI-MS imaging (approx. 20 min. per sample) is not 
compatible with point-of-care use. Transitioning to sparse DESI-MS analysis of tissue smears, 
as shown in previous work with brain cancer16 and independent studies with breast cancer,26 
would increase sample throughput and allow intraoperative use. Also, the direct MS analysis 
of oral brush biopsies,27 a routine method in oral cancer screening, using touch spray mass 
spectrometry28 would be an alternative to DESI that would provide similar diagnostic 
information29on a short timescale. The time to collect a single mass spectrum is on the order of 
milliseconds and statistical classification could be reduced to about a minute per sample. 
Further work is needed to validate this method prospectively, and to develop techniques for 
evaluating the technology for use in intraoperative margin assessment as well as in oral cavity 
cancer screening. 
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Figure 1. Histopathological evaluation (performed by DJS) and DESI-MS data for select 
samples. A&B) 1 corresponds to H&E stained image with pathological evaluation, 2-4 are ion 
images of m/z 563, 465, 885, on a grayscale with corresponding scale bar. A. Sample 35. B. 
Sample 36.  Scanned image of H&E stained Sample 36 with histopathology determined 
annotations delineating regions of interest.  B.  Scanned image of H&E stained Sample 35 with 
histopathology determined annotations delineating regions of interest. C. Average mass 
spectrum, normalized to the TIC and scaled by 100, of selected pixels of interest for Sample 
35 normal epithelial tissue. D. TIC normalized and scaled by 100 average mass spectrum of 
selected pixels of interest for Sample 35 (squamous cell carcinoma with collagen).  
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Figure 2. A. PCA score plot (PC1 vs. PC2) displays normal epithelial from SCC average mass 
spectra using DESI-MS imaging negative mode m/z range 400 - 600. SCC average mass spectra 
are red triangles and normal epithelial average mass spectra are green circles. B. PCA loading 
plot (PC1 vs. PC2) showing differentiation based on m/z 465 (cholesterol sulfate)
19
 (positive 
PC1 coefficients and positive and negative PC2 coefficients) and to a lesser extent m/z 563 
(dimer of oleic acid)
20
 (negative PC1 and PC2 coefficients). 
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Figure 3. Comparison of TIC Normalized (without scaling) maximum values of m/z 281, 465 
and 563 between normal epithelial (green) and SCC (red) from the DESI-MS imaging data.  
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Figure 4. A. Pixel prediction for m/z 200-1,000 for Sample 43. Red predicting squamous cell 
carcinoma and green predicting non-SCC. B. Pixel prediction for m/z 700-900 for Sample 43.  
C. Histopathology determination for Sample 43. 
 
 
 
 
 
Figure 5. A. Pixel prediction for m/z 200-1,000 for UC Davis Sample 30. Red predicting 
squamous cell carcinoma and green predicting normal epithelial tissue. B. Pixel prediction for 
m/z 700-900 for UC Davis Sample 30.  C. Histopathology determination of normal epithelium 
and skeletal muscle for UC Davis Sample 30. 
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Figure 6. A. Pixel prediction for m/z 200-1,000 for UC Davis Sample 24. Red predicting squamous 
cell carcinoma and green predicting non-SCC. B. Pixel prediction for m/z 700-900 for UC Davis 
Sample 24.  C. Histopathology determination of squamous cell carcinoma for UC Davis Sample 24.  
D. Average mass spectrum of selected pixels for UC Davis Sample 24. 
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Table 1: Cross Validation Confusion Matrix for DESI-MS imaging Prediction Rates: 
 Pathology  
Total Population 
(21 samples) 
SCC Normal 
SCC Prevalence 
(62%, 13/21) 
DESI-MS 
imaging 
PCA-
LDA 
SCC 13 1 
Positive Predictive 
Value 92.8% 
Normal 0 7 
 Negative Predictive 
Value 100% 
 
Accuracy 
(95%) 
True 
Positive 
Rate 100% 
 True 
Negative 
Rate 
87.5% 
 
Pixel by Pixel Prediction Models of Oral Cancer Samples 
 
 
 
 
 
 
Table 2: Confusion Matrix for m/z 700-900 DESI-MS imaging Prediction Rates: 
 Pathology  
Total Population 
(46 samples) 
SCC Normal 
SCC Prevalence 
(63%, 29/46) 
m/z 700-
900 Pixel 
by Pixel 
PCA-
LDA 
SCC 27 2 
Positive Predictive 
Value 93% 
Normal 2 15 
 Negative Predictive 
Value 88% 
 
Accuracy 
(91%) 
True 
Positive 
Rate 93% 
 True 
Negative 
Rate 88% 
 
 
